Drug utilization for common skin diseases: an outpatient based study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20195264Keywords:
Dermatology, Treatment, Core prescribing indicatorsAbstract
Background: Drug utilization studies are useful for understanding the pattern of drug use in any particular healthcare set-up. This data gives an insight to improve the medical treatment at different layers in the health system. The oobjective of the present study was to assess drug utilization patterns by using core prescribing indicators of WHO and to assess most commonly observed skin disease in Dermatology out patients department (OPD) of tertiary care hospital.
Methods: 246 prescriptions from Dermatology OPD were audited. Common skin diseases and the prescribing patterns were analysed from the prescriptions.
Results: Average 2.4 drugs per prescription were seen in this study. 38.7% drugs were from National Essential Drug List of India. All the drugs were prescribed by brand names. The fixed dose combinations accounted for 20.6% drugs prescribed. Dosage, dose and duration of treatment were written for 100% of prescriptions. Around 44 different skin diseases were diagnosed amongst 246 patients predominantly cutaneous fungal infections, acne, dermatitis, eczema and psoriasis. About 591 different drugs were used mainly corticosteroids (21%), antibiotics (17%), anti-allergic (16%), antifungals (11%). Common skin conditions receiving corticosteroids were dermatitis (9.9%), eczema (9.1%). Antibiotics (17%), antifungals (11%) and antivirals (1%) were commonly used antimicrobial agents. 55.2% drugs were administered topically while 44.6% received orally.
Conclusions: Prescriptions revealed a higher incidence of fungal and bacterial infections. All the medications were prescribed rationally. All prescriptions had proper dosage form, frequency of administration, duration of therapy and diagnosis. However, prescriber should be motivated for prescription of generic drugs and those from essential drug list.
Metrics
References
Baur B, Sarkar J, Manna N, Bandyopadhyay L. The pattern of dermatological disorders among patients attending skin OPD of a tertiary care hospital in Kolkatta, India. J Dent Med Sci. 2013;3(4):04-9.
Rook A, Savin JA, Wilkinson DS. The Prevalence, incidence and ecology of diseases of skin. In: Rook A, Wilkinson DS, Ebling FJ, Champion RH, Burton JL, ed. Text book of Dermatology. Mumbai, India: Oxford University Press; 1987: 39-53.
Devi TB, Zamzachin G. Pattern of skin diseases in Imphal. Indian J Dermatol. 2006;51(2):149-50.
Gupta V. Pattern of skin diseases in rural India: a hospital based study. Intl J Scientific Stud. 2015;3(1):44-7.
Soumerai SB. Factors influencing prescribing. Aust J Hosp Pharm. 1988;18:9-16.
Lamichhane DC, Giri BR, Pathak OK, Panta OB, Shankar PR. Morbidity profile and prescribing patterns among outpatients in a teaching hospital in Western Nepal. McGill J Med. 2006;9(2):126-33.
Krishnaswamy K, Kumar DB, Radhaiah G. A drug use survey- precepts and practice. Eur J Clin Pharmacol. 1985;29:363–70.
Michael JC, John T, Catherine H, Julie C, Victoria B, Rachid TA, et al. An audit of adverse drug reactions to aqueous cream in children with atopic eczema. The Pharmaceut J. 2003;271:747-8.
Sweileh WM. Audit of prescribing practices of topical corticosteroids in outpatient dermatology clinics in north Palestine. East Mediterran Health J. 2006;12(1/2):161-9.
Chester BG. Polypharmacy in elderly patients with diabetes. Diab Spectrum. 2002;15(4):240-8.
WHO Anatomical and Chemical Classification coding system (ATC/DDDIndex), 2013. Available at: http://www.whocc.no/atc_ddd_index/. Accessed on 16 January 2019.
World Health Organization. Model list of essential drug list for children, 2013. 4th ed; and World Health Organization. Model list of essential drug, 2015. 19th ed. Available at: http://www.who.int/medicines/publi cations/essentialmedicines/en/. Accessed on 16 January 2019.
National list of essential medicines of India. 2015. Avilable at: https://mohfw.gov.in › sites › default › files. Last accessed 16 January 2019.
World Health Organization: WHO ICD-10: Version 2010. Available at: http://apps.who.int/classifications /icd10/browse/2010/en. Accessed on 16 January 2019.
Thappa DM, Microanatomy of the Skin. Thappa DM, ed. In: Essential in Dermatology Microanatomy of the skin. 2nd ed. New Delhi; Jaypee Brothers Medical publishers; 2009: 1- 8.
Tikoo D, Chopra SC, Kaushal S, Dogra A. Evaluation of drug use pattern in dermatology as a tool to promote rational prescribing, JK Science. J Med Educ Res. 2011;13(3):128-31.
Minocha KB, Bajaj S, Gupta K, Gupta M. A clinico pharmacological study of outpatient prescribing pattern of dermatological drugs in an Indian tertiary hospital. Indian J Pharmacol. 2000;32:384-5.
Biswas NR, Biswas RS, Pal PS, Jain SK, Malhotra SP, Gupta A, et al. Patterns of prescriptions and drug use in two tertiary hospitals in Delhi. Indian J Physiol Pharmacol. 2000;44:109-12.
Georgekutty KV, Sambasivam N, Nagarajan M. A study on drug prescribing pattern in Madurai city. Indian J Pharmacol. 2002;34:361-2.
Shankar RP, Partha P, Nagesh S. Prescribing patterns in medical outpatients. Int J Clin Pract. 2002;56:549-51.
Maini R, Verma KK, Biswas NR, Agrawal SS. Drug utilization study in dermatology in a tertiary hospital in Delhi. Indian J Physiol Pharmacol. 2002;46:107-10.
Narwane SP, Patel TC, Shetty YC, Chikhalkar SB. Drug Utilization and cost analysis for common skin diseases in dermatology OPD of an Indian tertiary care hospital- a prescription survey. Br J Pharm Res. 2011;1(1):9-18.
Kshirsagar MJ, Langade D, Patil S, Patki PS. Prescribing patterns among medical practitioners in Pune, India. Bull World Health Organization. 1998;76(3):271-5.
Vineeta D, Sharad P, Ganachari MS, Santosh S. Assessment of drug prescribing pattern and cost analysis for skin disease in dermatological department of tertiary care hospital: an interventional study. J Pharmacovigil. 2016;4:3.
Downloads
Published
How to Cite
Issue
Section
